Masterclass in Imaging of Oncological Whole Body MRI

Nov 14th, 2018
London, --
GB
https://www.icimagingsociety.org.uk/index.cfm?task=meetings&meetingid=153
Phone:07956814964
This master class is a one-day workstation-based teaching course, which will highlight the application of whole-body MRI in cancer. This course is designed for radiologists interested to learn the daily application of whole-body MRI in clinical practice.
Latest in Home
A graphical abstract of the study.
FDG-PET/CT predicts outcomes in patients with HCC
May 22, 2026
'Ohne KI schaffen wir unsere Arbeit nicht mehr', sagt Univ.-Prof. Dr. med. Thorsten Bley, Direktor des Instituts für Diagnostische und Interventionelle Radiologie am Universitätsklinikum Würzburg.
RöKo 2026: "Wir sind Opfer unseres eigenen Erfolgs"
May 22, 2026
'Without AI, we can no longer manage our workload,' says Univ.-Prof. Dr. med. Thorsten Bley, Director of the Institute for Diagnostic and Interventional Radiology, Würzburg University Hospital.
RöKo 2026: "We are victims of our own success"
May 22, 2026
Breast Cancer3
AI model predicts 10-year breast cancer risk
May 20, 2026
More in Home
FDG-PET/CT predicts outcomes in patients with HCC
By Will Morton
Elevated FDG uptake was consistently associated with poorer overall survival.
May 22, 2026
A graphical abstract of the study.
RöKo 2026: "Wir sind Opfer unseres eigenen Erfolgs"
Gegen Ende des RöKo des RöKo brachte ein Vortrag zum Zukunftsprojekt Radiologie 2035, gut besucht, Thesen verdichtet, Theorien destilliert. Die gab es zuhauf.
May 22, 2026
'Ohne KI schaffen wir unsere Arbeit nicht mehr', sagt Univ.-Prof. Dr. med. Thorsten Bley, Direktor des Instituts für Diagnostische und Interventionelle Radiologie am Universitätsklinikum Würzburg.
RöKo 2026: "We are victims of our own success"
Toward the close of RöKo, a well-attended session on the future project Radiology 2035 distilled the congress's prevailing themes into a set of sharper theses and theories about the specialty's future, and there was no shortage of them.
May 22, 2026
'Without AI, we can no longer manage our workload,' says Univ.-Prof. Dr. med. Thorsten Bley, Director of the Institute for Diagnostic and Interventional Radiology, Würzburg University Hospital.
AI model predicts 10-year breast cancer risk
By Amerigo Allegretto
A mammography-based AI model showed strong performance in predicting 10-year breast cancer risk over clinical and other AI models.
May 20, 2026
Breast Cancer3
VIDEO RöKo 2026: Frank Wacker über die wachsende Bedeutung der IR
By Claudia Tschabuschnig
Interventionelle Radiologie könnte in einem Gesundheitssystem unter finanziellem Druck zunehmend wichtiger werden. Und warum es Deutschland immer noch schwer fällt, minimalinvasive Eingriffe in den ambulanten Bereich zu verlagern, erläutert Professor Frank K. Wacker in einem Videointerview beim RöKo 2026 in Leipzig.
May 20, 2026
Professor Frank K. Wacker, Direktor der Radiologie an der Medizinischen Hochschule Hannover, DeGIR-Präsident und gewählter DRG-Präsident, am DeGIR Campus beim 107. Deutschen Röntgenkongress in Leipzig.
VIDEO RöKo 2026: Frank Wacker on why IR is stuck in the basement and what comes next
By Claudia Tschabuschnig
At RöKo 2026 in Leipzig, Professor Frank K. Wacker spoke about why interventional radiology could become increasingly important in a healthcare system under financial pressure and why Germany still struggles to move minimally invasive procedures into the outpatient setting.
May 20, 2026
Professor Frank K. Wacker, Director of Radiology at Hannover Medical School, DeGIR President, and DRG President-elect, at the DeGIR Campus at the 107th German Radiology Congress in Leipzig.
AI devices vary widely in lung cancer detection
By Will Morton
Three devices helped detect more cancerous tumors, whereas the other four devices helped detect fewer tumors.
May 19, 2026
Cropped secondary capture examples. These are illustrative and not intended to imply superiority or inferiority of any device. (A) Posteroanterior radiograph in a 46-year-old female patient. The device correctly identified a right lower lobe nodule projected below the right hemidiaphragm and hilar lymphadenopathy. (B) Posteroanterior radiograph in an 86-year-old female patient with a classic Golden S sign highly suggestive of cancer. Three devices did not identify any findings. (C) The output from one device for the same radiograph as in B. The device placed a contour around the area of abnormality but mislabeled it as segmental collapse, and there are no other elements in the output to raise suspicion of cancer. (D) Posteroanterior radiograph in a 60-year-old male patient -- a case of confirmed lung cancer that was not deemed visible in retrospect. The device identified multiple false-positive abnormalities. (E) Posteroanterior radiograph in a 77-year-old female patient with two right lower lobe nodules. The device mislabeled the abnormality as infection -- a diagnostic term that could incorrectly influence clinical management. (F) Posteroanterior radiograph in a 77-year-old female patient with a right hilar tumor. Most of the lungs have been labeled by the device, with excessive overlap of the abnormality that pragmatically represents an incorrect result. All annotations shown were produced by the devices. LL = lung lesion, LO = lung opacity, PO = pleural other, TBC = tuberculosis.
VIDEO RöKo 2026: Nicolle Becke Franco gibt der Radiologie eine Stimme
By Claudia Tschabuschnig
RöKo 2026 hat Grenzen zwischen Disziplinen eingerissen, Nicolle Becke Franco hat ihnen eine Stimme gegeben.
May 19, 2026
Rollenwechsel: Nicolle Becke Franco, Gastgeberin von Inside Imaging – Powered by Bayer, diesmal selbst vor dem Mikro – beim 107. Deutschen Röntgenkongress in Leipzig.
VIDEO RöKo 2026: Nicolle Becke Franco on science communication in radiology
By Claudia Tschabuschnig
While RöKo 2026 lowered borders between disciplines, Nicolle Becke Franco gave them a voice.
May 19, 2026
Turning the tables: Nicolle Becke Franco, host of Inside Imaging – Powered by Bayer, steps in front of the mic herself at the 107th German Radiology Congress in Leipzig.
VIDEO: Stefan Schaller über Prävention und 650 Millionen Investment in Deutschland
By Claudia Tschabuschnig
Beim RöKo 2026 in Leipzig sprach Stefan Schaller, Head of Central Western Europe bei Siemens Healthineers, über Prävention als Chance, den Druck auf Krankenhäuser und warum das Unternehmen mitten in der deutschen Industriekrise massiv in neue Fabriken investiert.
May 18, 2026
Stefan Schaller, Head of Central Western Europe bei Siemens Healthineers, beim 107. Deutschen Röntgenkongress in Leipzig.
VIDEO RöKo 2026: Stefan Schaller on prevention and 650 million for Germany
By Claudia Tschabuschnig
At RöKo 2026 in Leipzig, Stefan Schaller, head of Central Western Europe at Siemens Healthineers, spoke about prevention as an opportunity, the pressure on hospitals, and why the company is investing heavily in new factories in Germany amid an industrial crisis.
May 18, 2026
Stefan Schaller, Head of Central Western Europe at Siemens Healthineers, at the 107th German Radiology Congress in Leipzig.
Röko 2026: "Europe as stress test for healthcare innovation"
By Claudia Tschabuschnig
"The real bottleneck today is no longer whether AI works technically," Mathias Goyen, Global Chief Medical Officer for Imaging at GE HealthCare, said at RöKo 2026. "The bottleneck is whether healthcare systems can adapt organizationally, financially, and politically fast enough to integrate it into routine care."
May 14, 2026
Professor Mathias Goyen (GE HealthCare) at RöKo 2026 on why Europe's cautious approach to AI reimbursement might be testing what actually works across fragmented healthcare systems.
Page 1 of 83
Next Page